Latest Interviews
Showing 1201–1215 of 1,991 transcripts.
Clear all filters- Milken Institute1h 1m
Creating a Culture of Biomedical Innovation
Mike Rea, Christopher Austin, Amitabh Chandra, Margaret Hamburg, Jennifer Miller, Jason Spangler
A cross-sector panel comprising leaders from NCATS, the FDA, Harvard, and Amgen redefined biomedical innovation as a value-driven process that balances patient outcomes with accessibility and ethical trust. By advocating for a collaborative culture that normalizes failure and breaks down silos between research, regulation, and reimbursement, the group proposed shifting metrics from simple speed to societal acceleration and integrity. The discussion ultimately highlighted critical misalignments in R&D funding, noting that commercial incentives currently neglect major disease burdens like mental health and neglected tropical diseases, necessitating a structural shift toward public-sector leadership.
- Milken Institute1h 4m
Digital Health Technology and Solutions
Steven Krein, Katie Agarwal, Matthew Stoudt, Sara Wajnberg, Joel White, Sarah Weinberg, John Birch, George Masregas, Lucia Savage, Hoyt Morgan, Paul Anthony, Lisa Fitzpatrick, Mike Goodman
The event convened leaders from Oscar Insurance, Maven Clinic, Applied VR, and Horizon Government Affairs to analyze how converging macro trends and $10 trillion in capital are reshaping global digital health. Despite rapid venture investment, the panel highlighted critical barriers including fragmented state licensing, stagnant Medicare reimbursement, and misaligned regulatory frameworks that force startups to pivot from consumer to employer models. Looking ahead, the industry aims to drive individualization and equity through unified data standards, risk-based FDA pre-certification, and cross-sector collaboration to eliminate friction in chronic pain management and women's health care.
- Milken Institute56 min
Mind and Body: Workplace Wellness
Stephen Sokoler, Kelley Vargo, Rachel Goldstein
Kelly Vargo and Steven Sockler presented evidence that integrating simple physical movements and mindfulness practices into the workplace significantly reduces global mortality risks and boosts organizational ROI through reduced absenteeism and increased productivity. Vargo advocated for the "Health 401K" concept using chair-based exercises and standing triggers, while Sockler detailed how meditation expands the prefrontal cortex and generates substantial financial savings, as demonstrated in case studies from Aetna and Humana. The session concluded that successful implementation relies on visible senior leadership modeling these behaviors to drive cultural change and utilizing data to secure executive buy-in for long-term wellness initiatives.
- Milken Institute1h 0m
Brain Health for Longevity: What Works? What Doesn't?
Nora Super, Alvaro Fernandez, Sarah Lock, David Perlmutter, Alfred Sandrock, Brian Van Buren, Jeff Wilkinson, Dr. Mark Hyman, Joe Maroon, Mark Fisher
Amidst a rapidly aging U.S. population where one in five residents will be over 65 by 2030, this event examines the convergence of biological mechanisms like autophagy and clinical breakthroughs to address the $716 trillion economic impact of cognitive decline. Panelists discuss a critical shift from late-stage treatment to early prevention, detailing how multimodal interventions—including sleep optimization, vascular health management, and disease-modifying therapies in the DIAN trial—can delay dementia onset by five to ten years. The discussion further emphasizes the necessity of overcoming diagnostic stigma and equity gaps to integrate neurotechnology and community support systems into a comprehensive public health strategy for brain longevity.
- Milken Institute57 min
Reimagining Medicare for Longer Lives
Joanne Kenen, Efrem Castillo, Nancy-Ann DeParle, Terry Fulmer, Darilyn Moyer, John, Saira, Corinne Purtill
This panel discussion analyzes the structural misalignment between the US healthcare system's acute-care origins and the modern demographic reality of an aging population living longer with chronic conditions. While bipartisan legislation and private sector innovations in Medicare Advantage are successfully shifting incentives toward value-based care and addressing social determinants, implementation is severely hindered by astronomical administrative burdens and fragmented health IT interoperability. Participants conclude that future progress requires integrating social services into medical models and leveraging private sector experimentation to streamline the transition away from volume-based reimbursement.
- Milken Institute56 min
Health-care Disruptors: New Models Changing the Landscape
Casey Ross, Ray Dorsey, Joel Dudley, Andrea Feinberg, Dan Liljenquist
A multidisciplinary panel led by Dr. Ray Dorsey, Dan Liljenquist, Dr. Andrea Feinberg, and Dr. Joel Dudley addressed critical healthcare failures, highlighting how telemedicine, generic drug shortages, nutritional interventions, and data fragmentation impact patient outcomes and system efficiency. The speakers detailed successful pilot programs, including University of Rochester's home-based Parkinson's care, CivicaRx's nonprofit generic manufacturing model, Geisinger's Fresh Food Pharmacy, and Mount Sinai's data-driven precision health initiatives, all of which demonstrated significant reductions in costs and mortality. Despite these proven efficacy metrics, the discussion underscored that widespread scalability remains constrained by rigid Medicare reimbursement policies, regulatory limits on social determinants of care, and fragmented data infrastructure that prevents algorithmic integration.
- Y Combinator55 min
After PMF: People, Customers, Sales by Mathilde Collin
Mathilde Cullen co-founded Front with Laurent Dufaux in Y Combinator's Summer 2014 batch to build an email collaboration platform that achieved zero voluntary attrition through a culture of radical transparency and a rigorous "10x hire" recruitment strategy. The company secured early product-market fit by prioritizing direct customer feedback, which led to a strategic pivot adding SMS integration and a pricing evolution from a freemium model to higher-tier subscriptions. By adhering to disciplined weekly metrics, maintaining a bottom-up sales motion, and fostering deep co-founder alignment, Front successfully scaled while navigating leadership challenges including the CTO's cancer diagnosis.
- Y Combinator55 min
The Path to $100B by Paul Buchheit
Google co-founder Paul Buchheit outlines the critical success factors for building billion-dollar companies, emphasizing the necessity of focusing on an exponential market shift and achieving deep product-market fit with a small, obsessive user base before scaling. Drawing from his experiences launching Gmail and selling FriendFeed to Facebook, Buchheit argues that startups must prioritize frugality, customer obsession, and the ability to handle network effects rather than chasing broad appeal or reacting to competitors. His framework stresses that true growth emerges from solving urgent customer problems with irrational conviction, a discipline he believes is often lost in large organizations that lack the cultural DNA for product-led innovation.
- Jane Street1h 7m
Marius Eriksen: Distributed, Incremental Dataflow Processing in the Cloud with Reflow
The Braille bioinformatics team has developed Reflow, an open-source workflow engine designed to treat biological data pipelines as functional programs rather than static dependency graphs. By enforcing a strict data model and dynamic cloud resource provisioning, the system automatically parallelizes tasks, caches results through referential transparency, and ensures reproducible computations via versioned "data spaces." Currently adopted by Grail, the Chan Zuckerberg Institute, and several biotech startups, Reflow reduces infrastructure complexity while enabling efficient incremental updates to massive genomic and machine learning pipelines.
- Milken Institute57 min
Data Disrupting Health
Meg Tirrell, Susannah Fox, Deborah Kilpatrick, Don Rucker
No verifiable event or decision-making process can be identified from the provided text due to its severe semantic incoherence and lack of factual substance. The recording consists of fragmented speech and unrelated topic cycles that fail to establish credible timelines, specific figures, or actionable outcomes regarding health, finance, or organizational development. Consequently, the content does not support a summary of any substantive meeting, expert discussion, or confirmed progress report.
- Milken Institute59 min
Finding a Cure for the Cost of Durable Therapies
Dan Mendelson, Yvonne Greenstreet, Joe Grogan, Michael Sherman, Mark Skinner, John Birch, Ian Kramer, Jupiter Lazmar
A panel of industry leaders, payers, and advocates highlighted the systemic friction between transformative gene therapies and traditional commercial models that rely on high-volume patient pools to amortize R&D costs. Participants detailed pricing pressures for one-time cures and chronic durable treatments while showcasing innovative risk-sharing agreements, such as Alnylam's outcomes-based pilot with Harvard Pilgrim Health Care, to manage financial exposure. Addressing these challenges, the group called for federal policy reform to eliminate "best price" disincentives and the adoption of flexible valuation frameworks that integrate patient-reported outcomes to prevent insurance affordability crises.
- Milken Institute59 min
Food is Medicine
Allison Aubrey, Tom Crohan, Wendy Johnson, Jason Karp, Dariush Mozaffarian, Greg Barrett, Terry
Addressing the global obesity and diabetes pandemic, a panel of experts from Tufts, Nestlé, John Hancock, and Torbillon discussed the paradox of rising chronic disease rates amidst growing consumer interest in "clean food." Key speakers highlighted transformative strategies such as John Hancock's Vitality program, which incentivizes healthy behaviors through insurance premiums, and the proposed "SNAP Plus" policy designed to save billions by subsidizing nutritious foods for low-income populations. Despite structural barriers like industry lobbying and inconsistent dietary guidelines, the group emphasized that integrating food into national security discourse and leveraging corporate innovation offers a viable path toward systemic health reform.
- Milken Institute58 min
Opioid Crisis: Examining National, State, and Local Responses and Impact
Dan Diamond, Shereef Elnahal, Thomas Graf, Elinore McCance-Katz, Nora Volkow
At the Milken Institute Future of Health Summit, federal and state leaders including Dr. Nora Volkow, Dr. Eleanor McCance-Katz, and Dr. Sharif El-Nahal convened with insurer representatives to address the heterogeneous nature of the opioid crisis through a multi-trajectory approach. The panelists detailed concrete strategies such as New Jersey's integration of medication-assisted treatment in correctional facilities, Horizon Blue Cross's shift away from non-evidence-based urine testing, and SAMHSA's efforts to mainstream addiction training in medical schools. Consensus emerged that sustainable outcomes require granular real-time data infrastructure and collaborative partnerships that empower local communities with the flexibility to tailor interventions to specific demographic and geographic needs.
- Milken Institute46 min
Partnerships in Global Health
Thomas Bollyky, Deborah Birx, Kathy Calvin, Bruce Gellin, Susan Sweeney
The provided text fails to describe a coherent event, as the source material is a corrupted and semantically incoherent machine generation containing contradictory health statistics and nonsensical procedural claims. While the fragmented output mimics a discussion on global public health involving various government departments and international projects, it offers no verifiable facts, actionable outcomes, or specific speaker identities. Consequently, no substantive summary of an actual meeting can be derived from the repetitive and hallucinated content presented.
- Y Combinator45 min
Understanding SAFEs and Priced Equity Rounds by Kirsty Nathoo
This presentation clarifies critical capitalization mechanics for founders by advocating for the mandatory use of post-money SAFEs to ensure transparent ownership tracking and simplify dilution calculations. It details how cumulative equity issuance from SAFE conversions, employee option pools, and priced rounds like Series A significantly impacts founder control, as demonstrated by a scenario where ownership drops from 100% to 51.5%. The analysis further warns against over-optimizing early valuation caps and mixing instrument types, emphasizing that proactive math is essential to prevent founders from retaining negligible equity after financing.